Bridgewater, N.J.-based Salix Pharmaceuticals is the GI affiliate of Valeant Pharmaceuticals and one of the largest GI-focused pharmaceutical companies in the world.
Here are four things to know.
1. Salix develops products for hepatic encephalopathy, IBS with diarrhea, opioid-induced constipation and ulcerative colitis.
2. Salix comprised approximately 18 percent of Valeant's $8.7 billion revenue for fiscal year 2017.
3. Valeant acquired Salix in 2015.
4. Salix is Valeant's most successful business after its Bausch + Lomb segment.
More articles on gastroenterology:
GI leader to know: Dr. Terry Baldwin of Illinois Gastroenterology Institute
Drs. Michael Kaczanowski, Seth Gross & more: 3 GI physicians making headlines
Self-employed gastroenterologists earn $24k more than employed: 4 statistics